Investment Professionals

Webinar Recording: Investing in the essential - healthcare & biotechnology

Recorded on the 2nd July 2020. 
In this webinar, we discussed:
What biotechnology is and how it is different from broad healthcare
Why investors should look outside Australia to the US
How biotechnology is being used to fight COVID-19
What the future of biotechnology and healthcare look like
Volatility and how to allocate to biotechnology in your portfolio
To watch the webinar recording, please click here. 

Global biotechnology in your clients’ portfolios

Biotechnology has hit the headlines during the COVID-19 pandemic as companies race for vaccines and treatments, but its growth prospects extend beyond this period. Australian investors may be well familiar with this industry, given the dominance of CSL, but may be missing exposure to the international market, in particular, the US, the global centre of biotechnology. Download the full article here What is biotechnology? Biotechnology is a sub-industry of the healthcare sector and specifically refers to technologies that use biological processes, capturing companies that focus on research, development, manufacturing and/or marketing of products based on biological and genetic information. The different types of biotechnology include biological drugs, vaccines, immunotherapy, gene therapy, orphan drugs and genetic engineering. ...

Megatrends Make Sense For Investors

Product In Focus: ETF Securities Future Present Range Megatrends are powerful forces that have the potential to cause long term structural changes in the economy and society. The Future Present range has been designed to give investors access to the emerging megatrends that are starting to define the world we live in. The range’s products positive performance is testament to investor trends. CURE up 22.0% year to date, ROBO 22.5%, TECH 20.7% and ACDC 7.1% (as at 12 April 2019) One of the most challenging as